Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk

2018-02-16 seekingalpha
I remind readers of our biggest loser to date and why risk management has been key to ROTY`s success. (146-0)

ROTY Edition 1 Volume 79: Limited Downside Catalysts Vs. Binary Risk

2018-02-14 seekingalpha
We discuss the difference between binary catalysts and those with limited downside, utilizing two recent examples. (166-3)

ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines

2018-02-13 seekingalpha
As always, readers are encouraged to do their own due diligence, manage risk appropriately, and avoid blindly following. (313-2)

ROTY Edition 1 Volume 77: Market Turmoil Continues - How To React

2018-02-09 seekingalpha
Recent market volatility is addressed and we discuss in depth how to react while sticking to one´s plan. (192-1)

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

2018-02-06 seekingalpha
Readers are encouraged to make their voices heard in my recent blog post if they haven´t already. (647-3)

ROTY Edition 1 Volume 75: The Future Of ROTY, Cascadian Acquired And Updates

2018-02-02 seekingalpha
I encourage readers to check out my recent blog post which goes into detail regarding changes to Seeking Alpha and consequently to ROTY. (539-1)

ROTY Edition 1 Volume 74: A New Feature For Readers, Updates And Trades

2018-01-30 seekingalpha
So far feedback has been positive for new features added, namely the position explanation section and updated model account snapshot. (330-0)

Merus: Important Catalysts In 2018

2018-01-27 seekingalpha
I recap the bullish thesis including why I am a fan of its partnership with Incyte. (84-0)

Biotech: The Gates Begin To Open

2018-01-26 seekingalpha
Biotech sector starts off the year strong with multiple acquisitions and partnerships, beginning to usher in the long-awaited M&A boom. (654-6)

ROTY Edition 1 Volume 73: New Features And A Controversial Swap Out

2018-01-25 seekingalpha
We are swapping out a current holding for a recent addition to the Contenders List (please read full write-up and be aware of risks). (158-4)

Syndax Pharmaceuticals Is In For A Potentially Transformative 2018

2018-01-25 seekingalpha
Shares of Syndax Pharmaceuticals (SNDX) have lost a quarter of their value since my initial write-up, far from the run-up that I was expecting in 2017. The stock had fallen off my radar, but thankfully as is often the case, a reader brought it back to my attention. (230-0)

ROTY Edition 1 Volume 72: Biotech Shines In January As We Manage Risk Appropriately

2018-01-23 seekingalpha
The biotech sector is performing very well thus far in 2018, while the ROTY model account has about doubled the returns of the IBB. (416-3)

BeiGene: A Promising Start To 2018

2018-01-23 seekingalpha
A well-executed secondary offering bodes well for the future, indicative of institutional interest and future business development. (130-1)

Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business

2018-01-21 seekingalpha
Sinocare (SHZ:300298), a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's (NYSE:JNJ) diabetes medical device subsidiaries (see story). With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market because they can no longer compete and revenues are falling. Sinocare is backed by China Jianyin Investment (JIC), a unit of sovereign wealth fund China Investment Corp. (150-1)

CUSIP: 60468T105